Particularly for those interested in biologics drug discovery but also for anyone currently using or curious about GeneFrontier's PUREfrex state-of-the-art recombinant cell free protein translation kits, GeneFrontier Corporation COO Takeshi Ebihara will be presenting a talk entitled "Unique in vitro Technologies for R&D of Biologics Including scFv, Fab, IgG and Cyclic Peptide." 

When: Wednesday, May 12 at 2:50 PM Eastern Standard Time
Where: Online. Click here for access information
Registration: required